Recognizing and managing on toxicities in cancer immunotherapy

Over the past 4 years, cancer immunotherapy has significantly prolonged survival time of patients with prostate cancer, melanoma, lung cancer, and liver cancer, but its side effects are also impressive. Different types of the immune therapeutic agents have different on-target or off-target toxicity...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Yang, Huifang Yu, Shuang Dong, Yi Zhong, Sheng Hu
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317694542
Tags: Add Tag
No Tags, Be the first to tag this record!